Merck KGaA

MRK

Company Profile

  • Business description

    Merck KGaA operates in three main segments: Life Science, Electronics, and Healthcare. The Life Science segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. The Electronics segment offers specialty materials to manufacture a variety of products, such as semiconductors and flat-screen televisions. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

  • Contact

    Frankfurter Strasse 250
    DarmstadtHE64293
    DEU

    T: +49 6151720

    https://www.emdgroup.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    63,160

Stocks News & Analysis

stocks

2 ASX shares that benefit from sticky inflation

Inflation is a key risk to shareholders. Here’s why these two ASX shares benefit from higher inflation.
stocks

Our view of Dexus / Scentre deal

Dexus acquires stake in Westfiend Chermside.
stocks

Undervalued ASX retailer benefiting from rebound in spending

Uplift in sales momentum continues.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,923.807.50-0.08%
CAC 408,147.2678.640.97%
DAX 4024,269.9483.450.35%
Dow JONES (US)48,587.93129.880.27%
FTSE 1009,743.5394.500.98%
HKSE25,628.88347.91-1.34%
NASDAQ23,252.9257.750.25%
Nikkei 22550,168.11668.44-1.31%
NZX 50 Index13,408.141.230.01%
S&P 5006,846.1918.780.28%
S&P/ASX 2008,635.008.90-0.10%
SSE Composite Index3,867.9221.42-0.55%

Market Movers